# Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma

Source: https://onco.cc/trials/nct05864534/  
OnCo record `nct05864534` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Transcranial focused ultrasound systems in Glioma & glioblastoma, run by Northwestern University, now recruiting.

## Summary

Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma is a phase 2 interventional study registered as NCT05864534 by Northwestern University, with 25 participants planned, started 2024-01-19 and due to reach its primary completion in 2031-07-31. Interventions recorded: Balstilimab, Botensilimab, Liposomal Doxorubicin, Sonocloud-9 (SC-9). Conditions recorded: Newly Diagnosed Glioblastoma, Glioblastoma, Isocitric Dehydrogenase (IDH)-Wildtype, Gliosarcoma, Glioblastoma Multiforme.

Linked to the technology Transcranial focused ultrasound systems because the registry names it ("sonocloud") among its interventions and Glioma & glioblastoma among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT05864534
- Phase: 2
- Setting: A Phase 2a Trial of Immune Modulation in Combination With Ultrasound-mediated Blood Brain Barrier Opening in Patients With Newly Diagnosed Glioblastoma
- Sponsor: Northwestern University
- Enrolled: 25

## Sources

- ClinicalTrials.gov NCT05864534: https://clinicaltrials.gov/study/NCT05864534

## Connected records

- cancers: [Glioma & glioblastoma](https://onco.cc/cancers/glioblastoma/)
- technologies: [Transcranial focused ultrasound systems (Exablate Neuro, SonoCloud)](https://onco.cc/technologies/transcranial-focused-ultrasound-systems/)
- drugs: [Balstilimab](https://onco.cc/drugs/balstilimab/), [Botensilimab](https://onco.cc/drugs/botensilimab/), [Doxorubicin](https://onco.cc/drugs/doxorubicin/)

---
JSON: https://onco.cc/api/v1/entities/nct05864534.json